Ebola Literature

Abbate JL, Becquart P, Leroy E, et al. Exposure to Ebola virus and risk for infection with malaria parasites, rural Gabon. Emerg Infect Dis 2019 (published online Dec 12)

Aruna A, Mbala P, Minikulu L, et al. Ebola virus disease outbreak — Democratic Republic of the Congo, August 2018-November 2019. MMWR Dec 20;68(50):1162-5

Biedron C, Lyman M, Stuckey MJ, et al. Evaluation of infection prevention and control readiness at frontline health care facilities in high-risk districts bordering Ebola virus disease-affected areas in the Democratic Republic of the Congo — Uganda, 2018. MMWR 2019 Oct 4;68(39):851-4

Caleo G, Theocharaki F, Lokuge K, et al. Clinical and epidemiological performance of WHO Ebola case definitions: a systematic review and meta-analysis. Lancet Infect Dis 2020 (published online Jun 25)

Clarke DK, Xu R, Matassov D, et al Safety and immunogenicity of a highly attenuated rVSVN4CT1-EBOVGP1 Ebola virus vaccine: a randomised, double-blind, placebo-controlled, phase 1 clinical trial. Lancet Infect Dis 2020 (published online Jan 14)

Claude KM, Underschultz J, Hawkes MT. Social resistance drives persistent transmission of Ebola virus disease in Eastern Democratic Republic of Congo: a mixed-methods study. PLOS One 2019 Sep 26;14(9):e0223104

Davis C, Tipton T, Sabir S, et al. Post-exposure prophylaxis with rVSV-ZEBOV following exposure to a patient with Ebola virus disease relapse in the  UK: an operational, safety and immunogenicity report. Clin Infect Dis 2019 (published online Nov 30)

Dodd LE, Follmann D, Proschan M, et al. A meta-analysis of clinical studies conducted during the West African Ebola virus disease outbreak confirms the need for randomized control groups. Sci Transl Med 2019 Nov 29;11(520)

Feldmann H, Sprecher A, Geisbert TW. Ebola [Review article]. N Engl J Med 2020 May 7;382(19):1832-42

Fischer K, Camara A, Troupin C, et al. Serological evidence of exposure to Ebolaviruses in domestic pigs from Guinea. Transbound Emerg Dis 2019 (published online Oct 18)

Fischer K, Suluku R, Fehling SK, et al. Ebola virus neutralizing antibodies in dogs from Sierra Leone, 2017. Emerg Infect Dis 2020 Apr;26(4)

Foeller ME, do Valle CC, Foeller TM, et al. Pregnancy and breastfeeding in the context of Ebola: a systematic review. Lancet Infect Dis 2020 (published online May 6)

Fries L, Cho I, Krahling V, et al. A randomized, blinded, dose-ranging trial of Ebola virus glycoprotein (EBOV GP) nanoparticle vaccine with Matrix-M adjuvant in healthy adults. J Infect Dis 2019 (published online Oct 11)

Grantz KH, Glaudot P, Kambala M, et al. Factors influencing participation in an Ebola vaccine trial among front-line workers in Guinea. Vaccine 2019 (published online Oct 14)

Gryseels S, Mbala-Kingebeni P, Akonda I, et al. Role of wildlife in emergence of Ebola virus in Kaigbono (Likati), Democratic Republic of the Congo, 2017. Emerg Infect Dis (Dispatch) 2020 Sep;26(9)

Halfmann PJ, Eisfeld AJ, Watanabe T, et al. Serological analysis of Ebola virus survivors and close contacts in Sierra Leone: a cross-sectional study. PLOS Negl Trop Dis 2019 Aug 1;13(8):e0007654

Herstein JJ, Le AB, McNulty LA, et al. Update on Ebola treatment center costs and sustainability, United States, 2019. Emerg Infect Dis 2020 May;26(5)

James PB, Wardle J, Steel A, et al. Pattern of health care utilization and traditional and complementary medicine use among Ebola survivors in Sierra Leone. PLOS One 2019 Sep 27;14(9):e0223068

Jombart T, Jarvis CI, Mesfin S, et al. The cost of insecurity: from flare-up to control of a major Ebola virus disease hotspot during the outbreak in the Democratic Republic of the Congo, 2019. Euro Surveill 2020 Jan 16;25(2):pii=1900735

Kangbai JB, Heumann C, Hoelscher M, et al. Severity score for predicting in-facility Ebola treatment outcome. Ann Epidemiol 2020 (published online Aug 5)

Kangbai JB, Heumann C, Hoelscher M, et al. Sociodemographic and clinical determinants of in-facility case fatality rate for 938 adult Ebola patients treated at Sierra Leone Ebola treatment center. BMC Infect Dis 2020 (published online Apr 21)

Kasereka MC, Ericson AD, Conroy AL, et al. Prior vaccination with recombinant vesicular stomatitis virus ─ Zaire Ebolavirus vaccine is associated with improved survival among patients with Ebolavirus infection. Vaccine 2020 Mar 23;38(14):3003-7

Keita AK, Vidal N, Toure A, et al. A 40 months follow-up of Ebola virus disease survivors in Guinea (Postebogui) reveals longterm detection of Ebola viral RNA in semen and breast milk. Open Forum Infect Dis 2019 (published online Nov 8)

Keita M, Diallo B, Mesfin S, et al. Subsequent mortality in survivors of Ebola virus disease in Guinea: a nationwide retrospective cohort study. Lancet Infect Dis 2019 (published online Sep 4)

Kelly JD, Wannier SR, Sinai C, et al. The impact of different types of violence on Ebola virus disease transmission during the 2018-2020 outbreak in the Democratic Republic of the Congo. J Infect Dis 2020 (published online Apr 7)

Kodish SR, Bio F, Oemcke R, et al. A qualitative study to understand how Ebola virus disease affected nutrition in Sierra Leone — a food value-chain framework for improving future response strategies. PLOS Negl Trop Dis 2019 Sep 10;13(9):e0007645

Kraft CS, Mehta AK, Varkey JB, et al. Serosurvey on healthcare personnel caring for patients with Ebola virus disease and Lassa virus in the United States. Infect Control Hosp Epidemiol 2020 (published online Jan 20)

Kurup D, Fisher CR, Smith TG, et al. Inactivated rabies virus-based Ebola vaccine preserved by vaporization is heat-stable and immunogenic against Ebola and protects against rabies challenge. J Infect Dis 2019 (published online Aug 3)

Lucas A, Kumakamba C, Lange C, et al. Serology and behavioral perspectives on Ebola virus disease among bushmeat vendors in Equateur, Democratic Republic of the Congo, after the 2018 outbreak. Open Forum Infect Dis 2020 (published online Jul 17)

Medley AM, Mavila O, Makumbi I, et al. Case definitions used during the first 6 months of the 10th Ebola virus disease outbreak in the Democratic Republic of the Congo — four neighboring countries, August 2018-February 2019. MMWR 2020 Jan 10;69(1):14-9

Mokuwa EY, Maat H. Rural populations exposed to Ebola virus disease respond positively to localized case handling: evidence from Sierra Leone. PLOS Negl Trop Dis 2020 Jan 21;14(1):e0007666

Mulangu S, Dodd LE, Davey RT Jr, et al. A randomized, controlled trial of Ebola virus disease therapeutics. N Engl J Med 2019 (published online Nov 27)

Nakiire L, Mwanja H, Pillai SK, et al. Population movement patterns among the Democratic Republic of the Congo, Rwanda, and Uganda during an outbreak of Ebola virus disease: results from community engagement in two districts — Uganda, March 2019. MMWR 2020 Jan 10;69(1):10-3

Nanziri C, Ario AR, Ntono V, et al. Ebola virus disease preparedness assessment and risk mapping in Uganda, August-September 2018. Health Secur 2020 Apr 17;18(2)

Nyakarahuka L, Schafer I, Balinandi S, et al. A retrospective cohort investigation of seroprevalence of Marburg virus and ebolaviruses in two different ecological zones in Uganda. BMC Infect Dis 2020 Jul 1;20(461)

Pavlin BI, Hall A, Hajek J, et al. Atypical clinical presentation of Ebola virus disease in pregnancy: implications for clinical and public health management. Int J Infect Dis 2020 (published online May 22)

Public Health England. Ebola virus disease: information for workers in at risk countries. Oct 9, 2019

Puig-Asensio M, Braun BI, Seaman AT, et al. Perceived benefits and challenges of Ebola preparation among hospitals in developed countries: a systematic literature review. Clin Infect Dis 2019 (published online Aug 13)

Richards P, Mokuwa E, Welmers P, et al. Trust, and distrust, of Ebola treatment centers: a case-study from Sierra Leone. PLOS One 2019 Dec 2;14(12):e0224511

Schmidt JP, Maher S, Drake JM, et al. Ecological indicators of mammal exposure to Ebolavirus. Philos Trans R Soc Lond B Biol Sci 2019 (published online Aug 12)

Sell TK, Shearer MP, Meyer D, et al. Influencing factors in the development of state-level movement restriction and monitoring policies in response to Ebola, United States, 2014-15. Health Secur 2019 Oct 7;17(5):364-71

Tapia MD, Sow SO, Ndiaye BP, et al. Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial. Lancet 2020 (published online Mar 19)

Tozay S, Fischer WA II, Whol DA, et al. Long-term complications of Ebola virus disease: prevalence and predictors of major symptoms and the role of inflammation. Clin Infect Dis 2019 (published online Nov 6)

Ververs M, Gabra M. Nutritional care for patients with Ebola virus disease. Emerg Infect Dis 2019 (published online Dec 4)

Vrancken B, Wawina-Bokalanga T, Vanmechelen B, et al. Accounting for population structure reveals ambiguity in the Zaire Ebolavirus reservoir dynamics. PLoS Negl Trop Dis 2020 (published online Mar 4)

Winters M, Nordenstedt H, Alvesson HM. Reporting in a health emergency: the roles of Sierra Leonean journalists during the 2014-2015 Ebola outbreak. PLoS Negl Trop Dis 2020 (published online May 21)

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson FoundationUnorthodox Philanthropy logo and text 'Leading Underwriter'3M logoGilead Become an underwriter»